Form 4: PAHC Grants RSUs to Senior VP Judith Weinstein

Phibro Animal Health Corp. granted 3,447 restricted stock units to Senior Vice President, General Counsel, and Corporate Secretary Judith Weinstein, vesting over three years.

Summary

• Judith Weinstein, Senior Vice President, General Counsel, and Corporate Secretary of Phibro Animal Health Corp. (PAHC), was granted 3,447 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs were granted on August 15, 2025, with a price of $0 per unit.
• The RSUs will vest in substantially equal installments on the first three anniversaries of August 1, 2025.
• Vesting is contingent upon Ms. Weinstein's continued employment through each applicable vesting date.

Sentiment

Score: 7

Explanation: The grant of equity to a key executive is generally a positive sign for retention and alignment of interests, indicating stability in leadership. It's a routine compensation event, not a major market mover, hence a neutral-to-positive score.

Positives

• Granting of RSUs to a key executive like the Senior Vice President, General Counsel, and Corporate Secretary can serve as a retention incentive, aligning her interests with long-term shareholder value.
• Equity compensation is a common practice to motivate and reward senior management.

Future Outlook

The RSUs are set to vest in substantially equal installments on the first three anniversaries of August 1, 2025, contingent on continued employment, indicating a planned long-term retention strategy for a key executive.

Management Comments

• The reported securities represent restricted stock units ('RSUs'), each of which represents a contingent right to receive one share of Class A Common Stock.
• The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

Industry Context

Granting restricted stock units to senior executives is a standard practice across various industries, including animal health, to align management incentives with shareholder interests and promote long-term retention. This aligns with typical executive compensation structures.

Comparison to Industry Standards

• The grant of RSUs to a Senior Vice President is a common form of long-term incentive compensation, comparable to practices at other publicly traded companies in the animal health sector such as Zoetis Inc. (ZTS) or Elanco Animal Health Incorporated (ELAN), which also utilize equity awards to retain and incentivize key personnel.
• The three-year vesting schedule is typical for such grants, providing a balance between immediate reward and long-term commitment.

Stakeholder Impact

• Shareholders: The grant aligns the interests of a key executive with shareholders, potentially leading to better long-term performance and retention of talent. Dilution from the shares issued upon vesting is minimal given the number.
• Employees: May signal stability in executive leadership and a commitment to retaining key talent.

Next Steps

• Vesting of RSUs on the first anniversary of August 1, 2025.
• Vesting of RSUs on the second anniversary of August 1, 2025.
• Vesting of RSUs on the third anniversary of August 1, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a senior executive. While it indicates a commitment to retaining key talent and aligning interests, it does not present new information that would fundamentally alter the investment thesis for Phibro Animal Health Corp. It's a standard operational event that does not warrant a change in an existing investment position.

Keywords

Phibro Animal Health Corp, PAHC, Restricted Stock Units, RSUs, Equity Compensation, Executive Compensation, Insider Transaction, Form 4, Corporate Governance, Judith Weinstein